Cardiovascular Overview | SpectraCell Laboratories

Now Offering COVID-19 PCR and Antibody Testing. Learn More


CardioMetabolic Testing

Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before a diagnosis of Type 2 Diabetes. SpectraCell’s CardioMetabolic, Pre-Diabetes, and LPP™ Plus Tests offer clinically relevant evaluation to help define risk for atherosclerotic cardiovascular disease (ASCVD), progression toward Type 2 Diabetes, and inflammation. These check points, along with a new CardioMetabolic Risk Assessment and Type 2 Diabetes Risk Assessment, help patients understand that not just one factor, but rather a constellation of factors, contributes to the genesis and progression toward cardiovascular disease including stroke, poor blood glucose control including Type 2 Diabetes, and/ or inflammation. Test results allow doctors to know when guidance, educational referral, and/ or treatment are necessary.

Learn More


The Pre-Diabetes biomarkers identify metabolic abnormalities that may progress into diabetes. Pre-Diabetes is a condition where the body cannot efficiently metabolize foods, especially carbohydrates, resulting in impaired glycemic (blood glucose) control, which may progress to diabetes when not properly treated or addressed through lifestyle changes.

Learn More

Lipoprotein Particle Profile (LLP)

Advanced Lipoprotein Particle testing for cardiovascular risk assessment.

Learn More